PAPER Liew TM

Distinct trajectories of subjective cognitive decline before diagnosis of neurocognitive disorders: Longitudinal modelling over 18 years.

J Prev Alzheimers Dis. 2025 Mar 7;:100123. Epub 2025 Mar 7 PubMed.

PAPER Rahman AU, Ali S, Saqia B, Halim Z, Al-Khasawneh MA, AlHammadi DA, Khan MZ, Ullah I, Alharbi M

Alzheimer's Disease Prediction Using 3D-CNNs: Intelligent Processing of Neuroimaging Data.

SLAS Technol. 2025 Mar 6;:100265. Epub 2025 Mar 6 PubMed.

PAPER Xu C

Enhanced social interaction protects cognition by preserving synapse numbers.

Brain Res. 2025 Mar 6;:149552. Epub 2025 Mar 6 PubMed.

PAPER Mielke MM, Fielding RA, Atkinson EJ, Aversa Z, Schafer MJ, Cummings SR, Pahor M, Leeuwenburgh C, LeBrasseur NK

Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study.

J Nutr Health Aging. 2025 Mar 7;29(5):100529. Epub 2025 Mar 7 PubMed.

PAPER Gong Y, Chen H, Gu Y, Shen J, Shen T, Ding Y, Lu M, Huang L, Yan M, Song P, Zhu Y, Rong S, Yuan C

Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality.

J Prev Alzheimers Dis. 2025 Mar 6;:100100. Epub 2025 Mar 6 PubMed.

PAPER Veljanoska E, Gomes S, Szende A, Cabra A, Munter-Young R, Gordois A

The Value of Positron Emission Tomography for Confirmation of Alzheimer's Disease in the Era of Amyloid-Targeting Therapies.

Value Health. 2025 Mar 5; Epub 2025 Mar 5 PubMed.

PAPER Zheng M

Snapshot of disease continuum centered on Alzheimer's disease: Exploring modifiable risk factors.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Mar 5;138:111316. Epub 2025 Mar 5 PubMed.

PAPER Chen H, Fang Z, Lin SL, Schachner M

L1CAM mimetic compound duloxetine improves cognitive impairment in 5xFAD mice and protects Aβ1-42-damaged HT22 cells.

Eur J Pharmacol. 2025 Mar 6;997:177476. Epub 2025 Mar 6 PubMed.

PAPER Elliott C, Jackson J, Findlay J, Williams G, Ghosh A, Ribe E, Ulmschneider M, Khan A, Ballard C, Aarsland D, Baillie GS, Harte M, Killick R

Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment.

Cell Signal. 2025 Mar 6;:111716. Epub 2025 Mar 6 PubMed.

PAPER Shahid F, Khan R, Mehmood A, Smadi AA, Ibrahim MM, Zheng Z

A Comprehensive Approach to Anticipating the Progression of Mild Cognitive Impairment.

Brain Res. 2025 Mar 6;:149549. Epub 2025 Mar 6 PubMed.

PAPER Kicik A, Kurt E, Hari E, Ulasoglu-Yildiz Ç, Gurvit H, Demiralp T

Impact of amygdala functional connectivity on cognitive impairment in Alzheimer's disease.

Neurol Sci. 2025 Mar 8; Epub 2025 Mar 8 PubMed.

PAPER Guo J, Wang P, Gong J, Sun W, Han X, Xu C, Shan A, Wang X, Luan H, Li S, Li R, Wen B, Chen R, Lv S, Wei C

The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021.

J Prev Alzheimers Dis. 2025 Mar 7;:100122. Epub 2025 Mar 7 PubMed.

PAPER Leroy M, Aziz AL, Schraen S, Deramecourt V, Skrobala E, Lecerf S, Pasquier F, Huin V, Bertoux M, Lebouvier T

Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis.

Rev Neurol (Paris). 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Zhang C, Xu J, Xu F, Xie X, Ji T, Wang C, Du J

1-Eplupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice.

Neurosci Lett. 2025 Mar 6;:138184. Epub 2025 Mar 6 PubMed.

PAPER Zhang B, Chen L, Kang M, Ai L, Tao Y

Gegen Qinlian Decoction improves Alzheimer's disease through TLR4/NF-κB/NLRP3 pathway.

Tissue Cell. 2025 Mar 1;95:102818. Epub 2025 Mar 1 PubMed.